Tumors (93.5% were sweat gland carcinomas) were detected in 85.7% (24/28) of Fance+/− mice, 27.3% (3/11) of Fance+/+ mice, and 22.2% (4/18) of Fance−/− mice (Table 1; Figure 13C). Here, FANCE is linked to sweat gland carcinoma.